Arbutus Biopharma (ABUS) Ownership - Who Owns Arbutus Biopharma?

1,272 Followers

Arbutus Biopharma (ABUS) Ownership Overview

0.05% Insiders

9.92% Mutual Funds

0.25% Other Institutional Investors

10.57% ETFs

79.21% Public Companies and

Individual Investors

The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 20.74% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 79.21% is owned by Public Companies and Individual Investors.

The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 10.17% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 10.57% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Saba Capital Management	xxxxxxxxxxxxx	$1673327
Dec 31, 2023	Woodline Partners Lp	xxxxxxxxxxxxx	$10517320
Dec 31, 2023	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$363670

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	7,958,865	Institution	4.04%	32,870,112
	7,476,615	Institution	3.80%	30,878,420
	6,460,580	Institution	3.28%	26,682,195
	3,935,631	Institution	2.00%	16,254,156
	3,455,100	Institution	1.75%	14,269,563
	2,695,269	Institution	1.37%	11,131,461
Michael Rockefeller	2,186,553	Institution	1.11%	9,030,464
	1,601,957	Institution	0.81%	6,616,082
	1,559,360	Institution	0.79%	6,440,157
	903,143	Institution	0.46%	3,729,981

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
6,460,580	Institution	3.28%	26,682,195
3,935,631	Institution	2.00%	16,254,156
2,695,269	Institution	1.37%	11,131,461
1,601,957	Institution	0.81%	6,616,082
1,559,360	Institution	0.79%	6,440,157
903,143	Institution	0.46%	3,729,981
703,917	Institution	0.36%	2,907,177
484,841	Institution	0.25%	2,002,393
432,384	Institution	0.22%	1,785,746
105,053	Institution	0.05%	433,869

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	4,811,847	Institution	2.44%	21,653,312
iShares Russell 2000 ETF	3,534,149	Institution	1.79%	14,666,718
SPDR S&P BIOTECH ETF	2,506,310	Institution	1.27%	10,401,187
Vanguard Extended Market ETF	1,731,789	Institution	0.88%	7,793,051
iShares Russell 2000 Growth ETF	1,166,508	Institution	0.59%	4,841,008
iShares Biotechnology ETF	1,107,797	Institution	0.56%	4,597,358
Schwab U.S. Small-Cap ETF	747,955	Institution	0.38%	3,104,013
Vanguard Russell 2000 ETF	745,105	Institution	0.38%	3,352,973
SPDR S&P Kensho New Economies Composite ETF	630,647	Institution	0.32%	2,617,185
Vanguard Health Care ETF	430,645	Institution	0.22%	1,937,903

FAQ

Who Owns Arbutus Biopharma Corporation (ABUS)?

According to the latest TipRanks data, approximately 0.25% of the company's stock is held by institutional investors, 0.05% is held by insiders, and 79.21% is held by retail investors.

What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.25% of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors.

What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors?

According to the latest TipRanks data, approximately 79.21% of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors.

Who owns the most shares of Arbutus Biopharma Corporation (ABUS)?

Vanguard owns the most shares of Arbutus Biopharma Corporation (ABUS).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.